Machine learning predictive model to identify metabolic status in Mexican children, using homeostasis model

Karen E Villagrana-Bañuelos1, Carlos E Galván-Tejada1, Antonio García-Domínguez1

  • 1Unidad Académica de Ingeniería Eléctrica, Universidad Autónoma de Zacatecas, Zacatecas, Zacatecas, Mexico, Instituto Mexicano del Seguro Social, México.

Gaceta Medica De Mexico
|October 8, 2025
PubMed

Insights

Total amylase activity shows potential in predicting metabolic syndrome and diabetes risk. This machine learning model aids in early identification of patients in the prepathogenic period.

Area of Science:

  • Biochemistry
  • Medical Diagnostics
  • Machine Learning

Background:

  • Childhood obesity is a significant global health concern, increasing the risk of metabolic syndrome and diabetes.
  • Early disease detection is crucial, shifting healthcare focus towards pre-disease stages.
  • Current diagnostic methods for established diseases rely on laboratory studies.

Purpose of the Study:

  • To evaluate the utility of total amylase activity in predicting metabolic syndrome and diabetes.
  • To develop a predictive model for identifying at-risk individuals before disease onset.

Main Methods:

  • Utilized a database of 101 Mexican patients.
  • Employed the homeostasis model assessment for insulin resistance (HOMA-IR) to categorize patients into normal, metabolic risk, and diabetes groups.
  • Applied Random Forest (RF) machine learning for predictive analysis using amylase activity and HOMA-IR.

Main Results:

  • The RF model achieved an area under the curve (AUC) of 0.7075.
  • Achieved a specificity of 0.7619, sensitivity of 0.7142, and overall accuracy of 0.7500.
  • Demonstrated the predictive capability of amylase activity and HOMA-IR.

Conclusions:

  • A feasible prediction model can be developed using total amylase activity and RF.
  • This model can assist in identifying individuals at risk for metabolic syndrome and diabetes during the prepathogenic phase.
  • Highlights the potential of biochemical markers for early disease prediction.
Abstract